ARCHIVES

NIH RFA Available

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

Also In sudden policy change, NIH proposes one-year ban on consulting by employees.

October 1, 2004

Nominations Sought For Women’s Health Achievement AwardsFor Medical Devices

February 7, 1997

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

June 26, 1992

Cancer Control RFA Announcements

March 9, 1979